Atlas Trials

F2G Ltd

17 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch F2G Ltd

RecordFirmDate
A Phase II Randomized Study to Evaluate Measures for Endpoint Derivation in Patients With Progressive or Refractory Disseminated Coccidioidomycosis (DCM ) Treated With Olorofim Plus Baseline SOC or Placebo Plus Baseline SOC (NCT07712484)F2G Ltd2026-12-01
Drug-drug Interaction (DDI) Study to Assess Effect of Itraconazole and Rifampicin Upon Olorofim (NCT04171739)F2G Ltd2019-11-18
Absorption, Metabolism and Excretion of 14C-olorofim in Man (NCT04039880)F2G Ltd2019-07-30
Radiolabelled IV and Oral Metabolism Study of F901318 (NCT02912026)F2G Ltd2019-05-01

Track F2G Ltd automatically

Every clearance here is in the API, with alerts when new ones post.